ABT - Executive Vice President Of Abbott Laboratories Sold $94K In Stock | Benzinga
Revealing a significant insider sell on March 5, Louis H Morrone, Executive Vice President at Abbott Laboratories (NYSE:ABT), as per the latest SEC filing.
What Happened: A Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday outlined that Morrone executed a sale of 801 shares of Abbott Laboratories with a total value of $94,918.
In the Tuesday's morning session, Abbott Laboratories's shares are currently trading at $119.64, experiencing a down of 0.33%.
Discovering Abbott Laboratories: A Closer Look
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Unraveling the Financial Story of Abbott Laboratories
Revenue Growth: Over the 3 months period, Abbott Laboratories showcased positive performance, achieving a revenue growth rate of 1.49% as of 31 December, 2023. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces ...